✨ Your Portfolio is fetched and updated from zerodha.
Nano Agriculture

Genomic Valley Biotech Ltd.

GVBL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹8 Cr.
P/E
76.09

Genomic Valley Biotech Ltd.

  • Genomic Valley
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

FAQs on Genomic Valley Biotech Ltd. Shareprice

Genomic Valley has given better returns compared to its competitors.
Genomic Valley has grown at ~1.29% over the last 5yrs while peers have grown at a median rate of 0.0%

Genomic Valley is not expensive.
Latest PE of Genomic Valley is 76.09, while 3 year average PE is 97.82.
Also latest EV/EBITDA of Genomic Valley is 42.28 while 3yr average is 84.36.

View FAQ's On Business

Growth Table

  • Genomic Valley Biotech Ltd.
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

Balance Sheet

  • Genomic Valley Biotech Ltd.
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Genomic Valley Biotech Ltd.
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

Cash Flow

  • Genomic Valley Biotech Ltd.
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Genomic Valley Biotech Ltd.
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

Quarterly Results

  • Genomic Valley Biotech Ltd.
  • Omega Ag-Seeds
  • Shri Mahalaxmi Agri

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Genomic Valley Biotech Ltd. Financials

Balance sheet of Genomic Valley is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Genomic Valley is increasing.
Latest net debt of Genomic Valley is -₹0.01 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹0.07 Crs.

The profit is oscillating.
The profit of Genomic Valley is ₹0.36 Crs for Mar 2025, ₹0.02 Crs for Mar 2024 and ₹0.65 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Genomic Valley latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech